Abcodia

Recent Finacing

Equity

Recent Raise

$8.2M

Abcodia develops molecular diagnostic tests for early cancer detection using longitudinal serum biobanks and personalized biomarker-dynamics algorithms (eg. CA19.9 pancreatic test), advancing biomarker discovery and clinical validation.